BTIG Biotechnology Conference 2019

BTIG Biotechnology Analysts Bert Hazlett, Amanda Murphy, CFA, and Thomas Shrader, PhD, CFA, hosted the BTIG Biotechnology Conference 2019 in New York on Monday, August 12, 2019. The private conference included one-on-one meetings and in-depth panel discussions.

Topics for discussion included treatment for sickle cell disease; solid and liquid tumors; TTR amyloidosis; lipids; central nervous system therapeutics; and targeted oncology.

For more information about the conference, please contact a BTIG representative or email [email protected].


This information was prepared for BTIG, LLC institutional clients. The information contained herein has been gathered from multiple sources and is believed to be reliable. However, BTIG, LLC has not independently verified the accuracy of the content and does not make any representations as to the accuracy or completeness of this information. The information is subject to change without notice and BTIG, LLC has no obligation to provide any updates or changes. BTIG, LLC is providing this data for informational purposes and does not believe that it is sufficient to base an investment decision on. This information should not be regarded as a solicitation or recommendation of any particular security or to engage in any trading strategy. BTIG, LLC does and may seek to do business, including investment banking and/or other capital markets business, with companies which are the subject of Corporate Access services.